Tag: MHRA approval

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) approved Sebetralstat (Ekterly) on July 15, 2025, as the first oral ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Alyftrek, a triple combination medicine for cystic fibrosis, offering new ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved lazertinib for use with amivantamab to treat adults with non-small ...

In a significant development for patients with Duchenne muscular dystrophy (DMD), the Medicines and Healthcare products Regulatory Agency (MHRA) has ...

    With the ongoing fight against COVID-19 in mind, the Medicines and Healthcare products Regulatory Agency (MHRA) has approved ...

30 October 2024 – In a significant step for cancer treatment, the UK Medicines and Healthcare products Regulatory Agency (MHRA) ...

New news in the fight against Alzheimer’s disease. The Medicines and Healthcare products Regulatory Agency has approved the licence for ...

Good news, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has approved eplontersen (also known as Wainua) for the ...

In a landmark decision today, the Medicines and Healthcare products Regulatory Agency (MHRA) approved capivasertib (Truqap) for patients with advanced ...

Today, on the 6th of March, 2024, the Medicines and Healthcare products Regulatory Agency (MHRA) made a landmark decision, granting ...